StonvexLoading…
StonvexStonvexStonvexCore line items from CRCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $159.47M | $708.78M | $505.18M | $334.75M |
Operating Income | $22.89M | $96.03M | $82.10M | $59.45M |
Net Income | $20.32M | $76.70M | $68.91M | $24.49M |
EPS (Diluted) | $0.10 | $0.35 | $0.32 | $0.23 |
Total Assets | $543.76M | $580.81M | $564.25M | $721.51M |
Total Liabilities | $186.27M | $237.25M | $205.86M | $412.57M |
Cash & Equivalents | $236.50M | $256.22M | $187.87M | $298.06M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 209.90M | 211.34M | 212.19M | 212.47M |